Displaying 51-100 of 206 result(s).
Recent Articles
- Newmark's Howard W. Lutnick: A Vision for Commerce Leadership
- Cyclical Stock Gains Drive S&P 500 Higher Amid Tech Setbacks
- Ashford Hospitality Trust Transforms Le Pavillon Hotel
- Thanksgiving Movie Releases: A Boost for AMC and Cinemark
- Replimune Advances RP1 for Melanoma via FDA Application
- Virpax Pharmaceuticals Expands Research in Pain Management Solutions
- eGain's Stock Buyback Program Extended Through 2025
- NXP Semiconductors Declares Exciting Q4 Interim Dividend
- Howard Lutnick's Nomination and Newmark’s Growth Prospects
- CBRE Group Enhances Stock Buyback: A $5 Billion Opportunity
- Phoenix Motor Faces Nasdaq Compliance Challenges Amid Growth
- Richard N. Frommer Strengthens Prairie Operating Board
- SL Green Realty's Bold Move: $400 Million Stock Offering
- Knightscope Moves Forward with Public Offering Plans Amid Challenges
- Marjorie Taylor Greene Joins Forces with Elon Musk for Efficiency
- Gap Inc. Boosts Sales Outlook Amid Strong Holiday Demand Trends
- Gap Inc. Offers Positive Outlook for Holiday Shopping Season
- Brazil Stock Market Trends and Key Indicators Update
- McKinsey Nears Agreement to Resolve Opioid Investigation Issues
- Canadian Stock Performance: S&P/TSX Reaches New Heights
- OpenAI Explores Development of Innovative Web Browser
- Colombia's Stock Market Shows Positive Momentum with COLCAP Gains
- Positive Trends in the Mexican Stock Market and Key Players
- Introducing a Unique Film Festival Experience this December
- Government Funding Boosts Avianor's Aerospace Innovation
- Inframark Secures Long-Term Wastewater Management Partnership
- Nancy Mace's Stand on Gender Bathroom Policy Explained
- Invesco Canada Reveals November Cash Distributions for ETFs
- Lilium N.V. Investors Should Explore Legal Options Now
- Investors Can Step Forward in Iris Energy Legal Action
- Bumble Inc. Faces Securities Fraud Lawsuit Amid Investor Concerns
- Investors Urged to Join Paragon 28, Inc. Securities Class Action
- Innocan Pharma Reports Impressive Revenue Growth in Q3
- CAMP4 Therapeutics: Transformative Quarter and IPO Success
- Insights on MDB Capital Holdings' Q3 2024 Performance
- Nanalysis Achieves Remarkable Growth in Q3 2024 Results
- Natural Grocers Reports Strong Fiscal 2024 Performance
- Elastic Reports Strong Q2 Performance, Beats Earnings Expectations
- Logility Supply Chain's Impressive Q2 Earnings Performance
- Matthews International Posts Fiscal Year-End Financial Results
- Gap Inc. Delivers Strong Q3 Results and Uplifts Expectations
- Gap Inc. Exceeds Q3 Earnings Estimates with Strong Growth
- Insights into Matthews International's Recent Earnings Report
- Intuit Reports Strong Q1 Results While Outlook Raises Concerns
- Investors Can Drive Class Action Against Metagenomi, Inc.
- Calls for Clemency: Lawmakers Advocate for Cannabis Prisoners
- Tevogen Bio CEO Acknowledges Shareholder Support and Strategy
- Midnight Hub Investors Urged to Act on Class Action Opportunity
- Investors Take Notice: Lilium N.V. Class Action Lawsuit News
- Xerox Holdings Faces Class Action Suit Amid Major Issues